Author: Dan D. Aridor

I hold an MBA from Columbia Business School (1994) and a BA in Economics and Business Management from Bar-Ilan University (1991). Previously, I served as a Lieutenant Colonel (reserve) in the Israeli Intelligence Corps. Additionally, I have extensive experience managing various R&D projects across diverse technological fields. In 2024, I founded INGA314.com, a platform dedicated to providing professional scientific consultations and analytical insights. I am passionate about history and science fiction, and I occasionally write about these topics.

Critical Technical Analysis: SARS-CoV-2 Protein Aggregation Study and Vaccine Spike Protein Implications This critical analysis reveals significant methodological flaws in the original study while uncovering genuine concerns about vaccine-induced spike protein behavior. The evidence suggests:

05/08/2025

Author: Dan D. Aridor

When Genetics Can’t Tell the Whole Story – A Critical Look at Gut-Brain Research

When Medical Research Goes Off the Rails: A Complete Logical Breakdown of a Long COVID Brain Study

Critical Technical Analysis: SARS-CoV-2 Protein Aggregation Study and Vaccine Spike Protein Implications This critical analysis reveals significant methodological flaws in the original study while uncovering genuine concerns about vaccine-induced spike protein behavior. The evidence suggests:

INGA314 Analysis Summary: COVID, Vaccines, and IL-6 Pathways discussion with GROK

When certainty masks uncertainty: unpacking paradoxes in COVID variant predictions

Enhancing Scientific Communication: An inga314 Case Study

The Missing Half of the Equation: Why Ignoring Vaccine Side Effects Invalidates the Entire Analysis

When Prestigious Science Goes Wrong: A Deep Dive Into Logical Flaws That Fool Even Cell Journal

Good science helps people. Bad science that masquerades as good science can hurt them.

When “More is Better” Logic Goes Wrong: A Critical Look at High-Dose Creatine Claims